The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action.
about
Cardiovascular drugs in the treatment of infantile hemangiomaAnalysis of factors affecting the therapeutic effect of propranolol for infantile haemangioma of the head and neck.Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study.Propranolol: Effectiveness and Failure in Infantile Cutaneous HemangiomasNd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children.Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective studyOral atenolol therapy for proliferating infantile hemangioma: A prospective study.Stress, catecholaminergic system and cancer.Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.Propranolol for gastrointestinal bleeding in two patients with continuous flow left ventricle assist device.Infantile hemangioma: pathogenesis and mechanisms of action of propranolol.Efficacy and Safety of 2% Topical Propranolol Cream for the Treatment of Proliferating Infantile Strawberry Hemangiomas.A prospective study of topical carteolol therapy in Chinese infants with superficial infantile hemangioma.Consensus statement for the treatment of infantile haemangiomas with propranolol.Quality of life in children with infantile hemangioma: a case control study.Das infantile Hämangiom: Pathogenese und Wirkmechanismus von Propranolol.Infantile hemangioma: factors causing recurrence after propranolol treatment.Development and characterization of a nanoemulsion containing propranolol for topical delivery.Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management.Effects of Propranolol on Neurodevelopmental Outcomes in Patients with Infantile Hemangioma: A Case-Control Study.
P2860
Q26769978-2FDA9C2E-9E55-4897-9274-7088B3A606E9Q33671872-E5975A8E-0FDC-4A1E-A0AB-8EE786DBA965Q33685473-7CA9BE27-EC0C-4448-A4F7-9D7C067765C6Q36164771-AA9DAB35-8146-4AE0-9109-E73A4DBACF64Q36211734-FB4E0A1B-D4AF-409C-8E4A-6EE90C1268A5Q37181444-D3BBF9A2-5913-4F06-B914-FC04A588CA0AQ37205732-31F8A042-9126-48CB-99F9-464C5E65ED3AQ38892059-3AD7D482-8AB6-4B2B-A0E5-3AF701B083D6Q39027849-45F162E9-6EB5-46DD-B90B-EBD5E1278AEFQ47246801-497A1943-FF1A-4A0C-8903-3D6BD05B786AQ47386049-2A3B5EAE-E912-4877-A3CC-97FBA9323DA4Q47860742-68CA8A19-D34E-4294-8BD4-2CF0DC4DABF8Q48112293-8073968E-67D8-4670-81C0-B29D3DE51040Q48174382-9F9C90D4-02AC-4C08-9E85-4C2BAC3EC501Q49308699-7CAD043C-8BAE-482B-AF6C-6061C7C47F00Q49932201-538CB693-ADDE-425C-95FB-7DDCFC0A49BCQ50092811-9B3EA148-B1BB-4032-B98E-0A72E18372C7Q55003101-C3854DCD-B88F-493D-829C-4E58A716BD14Q55155196-FAF78853-C49A-4A26-A53D-374599372336Q55266898-DE313778-2E38-43D7-A9EB-153BE54259C7
P2860
The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The use of propranolol in the ...... otential mechanisms of action.
@en
type
label
The use of propranolol in the ...... otential mechanisms of action.
@en
prefLabel
The use of propranolol in the ...... otential mechanisms of action.
@en
P2093
P2860
P356
P1476
The use of propranolol in the ...... otential mechanisms of action.
@en
P2093
P2860
P356
10.1111/BJD.13388
P407
P577
2014-12-17T00:00:00Z